↓ Skip to main content

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update

Overview of attention for article published in Frontiers in Pharmacology, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
video
1 YouTube creator

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
Published in
Frontiers in Pharmacology, May 2021
DOI 10.3389/fphar.2021.678546
Pubmed ID
Authors

Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 17%
Student > Ph. D. Student 2 11%
Student > Master 2 11%
Student > Bachelor 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 9 50%
Readers by discipline Count As %
Medicine and Dentistry 6 33%
Immunology and Microbiology 2 11%
Unknown 10 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2022.
All research outputs
#18,559,907
of 22,986,950 outputs
Outputs from Frontiers in Pharmacology
#8,332
of 16,272 outputs
Outputs of similar age
#318,403
of 438,308 outputs
Outputs of similar age from Frontiers in Pharmacology
#471
of 920 outputs
Altmetric has tracked 22,986,950 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,272 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,308 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 920 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.